Analysis of the remote results of treatment of patients with allergodermatoses using an angioprotective drug, multiprobiotic and topical calcineurin inhibitor.

Abstract

Optimizing the treatment of patients with allergic dermatoses is a relevant task of modern dermatovenerology. Allergodermatoses are a common group of allergic skin diseases, which in recent years have a tendency to a more severe clinical course with widespread skin damage, frequent relapses, and the development of resistance to basic treatment means. It results in the reduction of patients' work capacity and social activity and justifies the relevance of increasing the effectiveness of their treatment. Allergic dermatoses are found to be multifactorial diseases. Changes in the immune and endocrine regulation, intestinal dysbiosis, disorders of skin microcirculation, etc., are important in their development, which should be taken into account when prescribing a comprehensive therapy to such patients. The aim of the study. To evaluate the remote results of the comprehensive treatment of patients with allergic dermatoses using a multiprobiotic, an angioprotective drug, and a topical calcineurin inhibitor.